Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Triple inhaled therapy in asthma: Beliefs, behaviours and doubts.
Bagnasco D, Ansotegui I, Baiardini I, Benfante A, Bernstein JA, Bikov A, Bondi B, Boulet LP, Panaitescu C, Canonica GW, Chong-Neto H, Dubuske L, El-Owaidy R, Ferraris M, Filipovic M, Gonzalez-Barcala FJ, Guidos Fogelbach G, Ivancevich JC, Jusufovic E, Kowal K, Lantieri F, Mahboub B, Mihaicuta S, Mincarini M, Nedeva D, Novakova P, Novakova S, Nunes C, Ricchiuto FR, Santus P, Scichilone N, Steiropoulos P, Tiotiu A, Tomasello A, Virchow JC, Yadav R, Zunino S, Braido F. Bagnasco D, et al. Among authors: benfante a. Pulm Pharmacol Ther. 2024 Dec;87:102333. doi: 10.1016/j.pupt.2024.102333. Epub 2024 Nov 19. Pulm Pharmacol Ther. 2024. PMID: 39571784 Free article.
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab.
Di Bona D, Bilancia M, Crimi C, Daddato M, Benfante A, Caiaffa MF, Calabrese C, Campisi R, Nolasco S, Carpagnano GE, D'Amato M, Pelaia C, Pelaia G, Maglio A, Scichilone N, Scioscia G, Spadaro G, Triggiani M, Carrieri I, Valenti G, Vatrella A, Macchia L, Crimi N. Di Bona D, et al. Among authors: benfante a. Clin Exp Allergy. 2024 Oct 10. doi: 10.1111/cea.14584. Online ahead of print. Clin Exp Allergy. 2024. PMID: 39390847
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
Jackson DJ, Wechsler ME, Jackson DJ, Bernstein D, Korn S, Pfeffer PE, Chen R, Saito J, de Luíz Martinez G, Dymek L, Jacques L, Bird N, Schalkwijk S, Smith D, Howarth P, Pavord ID; SWIFT-1 and SWIFT-2 Investigators; SWIFT-1 Investigators; SWIFT-2 Investigators. Jackson DJ, et al. N Engl J Med. 2024 Dec 19;391(24):2337-2349. doi: 10.1056/NEJMoa2406673. Epub 2024 Sep 9. N Engl J Med. 2024. PMID: 39248309 Clinical Trial.
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study.
Crimi C, Nolasco S, Noto A, Maglio A, Quaranta VN, Di Bona D, Scioscia G, Papia F, Caiaffa MF, Calabrese C, D'Amato M, Pelaia C, Campisi R, Vitale C, Ciampo L, Dragonieri S, Minenna E, Massaro F, Gallotti L, Macchia L, Triggiani M, Scichilone N, Valenti G, Pelaia G, Foschino Barbaro MP, Carpagnano GE, Vatrella A, Crimi N; Southern Italy Network on Severe Asthma Therapy. Crimi C, et al. J Allergy Clin Immunol Pract. 2024 Dec;12(12):3315-3327. doi: 10.1016/j.jaip.2024.08.033. Epub 2024 Aug 27. J Allergy Clin Immunol Pract. 2024. PMID: 39197750 Free article.
100 results